Evaluation of flecainide acetate in the management of patients at high risk of sudden cardiac death
- 27 February 1984
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 53 (5) , B108-B111
- https://doi.org/10.1016/0002-9149(84)90513-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Electrophysiologic and antiarrhythmic effects of oral flecainide in patients with inducible ventricular tachycardiaJournal of the American College of Cardiology, 1983
- Flecainide versus quinidine for treatment of chronic ventricular arrhythmias. A multicenter clinical trial.Circulation, 1983
- Suppression of complex ventricular arrhythmias by oral flecainideClinical Pharmacology & Therapeutics, 1982
- Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainideThe American Journal of Cardiology, 1981
- Clinical electrophysiologic study of antiarrhythmic properties of flecainide: Acute intraventricular delayed conduction and prolonged repolarization in regular paced and premature beats using intracardiac monophasic action potentials with programmed stimulationAmerican Heart Journal, 1981
- Oral Flecainide Acetate for the Treatment of Ventricular ArrhythmiasNew England Journal of Medicine, 1981
- Antiarrhythmic effects of flecainideClinical Pharmacology & Therapeutics, 1980
- Electrophysiological Effects of a New Antiarrhythmic Agent, Flecainide, on the Intact Canine HeartJournal of Cardiovascular Pharmacology, 1979
- Antiarrhythmic and Hemodynamic Actions of Flecainide Acetate (R-818) in the Ischemic Porcine HeartJournal of Cardiovascular Pharmacology, 1979
- The use of single plane angiocardiograms for the calculation of left ventricular volume in manAmerican Heart Journal, 1968